AIDS News and Research

RSS

Boehringer Ingelheim continues providing non assert declarations to manufacture HIV/AIDS medicines

Boehringer Ingelheim continues to be willing to provide WHO qualified generic pharmaceutical companies non assert declarations to manufacturer and export products containing the HIV/AIDS medication nevirapine to Rwanda and other defined developing countries.

20 Oct 2009

GlaxoSmithKline to allow Apotex continue manufacturing their drug in Rwanda

GlaxoSmithKline Inc. (GSK) As part of its broad commitment to improving access to medicines and its ongoing support for Canada's Access to Medicines Regime (CAMR), GlaxoSmithKline confirms it will not object - through CAMR - to allow Canadian company (Apotex) to continue manufacturing their drug for the treatment of HIV/AIDS in Rwanda.

20 Oct 2009

AHF reiterates its disappointment over the presentation of Thai HIV vaccine study data

In anticipation of today’s controversial presentation of the Thai HIV vaccine study data at the AIDS Vaccine Conference in Paris, AIDS Healthcare Foundation (AHF) reiterated its disappointment at the news that data that seriously undermined the purported success of the trial were not released publicly when other, more favorable data were reported late last month.

20 Oct 2009

Trial collaborators present results from Prime-Boost HIV Vaccine Clinical Trial

Detailed results from the Prime-Boost HIV Vaccine Clinical Trial involving more than 16,000 adult volunteers in Thailand show that an investigational HIV vaccine regimen was safe and modestly effective at reducing the rate of HIV infection compared to placebo.

20 Oct 2009

Shire Canada supports initiative for further access to antiretroviral medicine for Rwanda

Shire Canada Inc., a division of Shire plc, announced today its voluntary cooperation to enable further royalty-free access to HIV/AIDS medicines for Rwanda as part of ongoing collaborative efforts to improve health and save lives in the developing world.

20 Oct 2009

Opinions: HIV vaccine; HIV resources help promote global disease control; U.S. fight against world hunger

Seth Berkley, president and chief executive of the International AIDS Vaccine Initiative, in a New York Times opinion piece examines how the "pessimism" over the recent controversy surrounding the results of an experimental HIV vaccine tested in Thailand "may ultimately thwart other efforts to develop an AIDS vaccine.

20 Oct 2009

DC 'squanders' AIDS money on questionable groups despite urgent needs

A Washington Post investigation has found that the city with the highest AIDS rate in the United States, Washington, D.C., has awarded millions of dollars to often ineffective groups with little oversight. Officials failed to act when information about waste and abuse became available, and in the worst case one may have helped channel funding to relatives who operated an AIDS charity out of their nightclub. Meanwhile, AIDS patients waited years for treatment, faced needs legitimate agencies were unable to meet, and in one case, died alone on a park bench within a couple of miles of a dozen nonprofits meant to care for AIDS patients (Cenziper, 10/18).

20 Oct 2009

Scientists find cause for lupuslike disease in mice

Macrophages, the scavenger cells of the body's immune system, are responsible for disposing of dying cells. Stanford University School of Medicine researchers have identified one pathway in this important process in mice that, if disrupted, causes a lupuslike autoimmune disease.

19 Oct 2009

Innovative financing for global health issues discussed at Nairobi meeting

As more countries prepare to introduce a voluntary travel tax to help fight HIV/AIDS and other diseases worldwide, Philippe Douste-Blazy, chair of UNITAID and a U.N. special advisor on innovative development financing said at a recent event in Nairobi, Kenya, that "the airline levy gives participating developing nations an opportunity to contribute to treatment in their countries rather than depending on handouts from the developed world," the Standard reports.

19 Oct 2009

Also in Global Health News: Asia-Pacific reproductive health; developing country medical waste disposal; draft bill in Uganda; diarrhea deaths in China

"China has called on Asia-Pacific countries to attach greater importance to population and family planning and put more funds into the reproductive health and family planning programmes," the Daily Times reports (10/19).

19 Oct 2009

Campaign seeks to hold governments accountable to meeting MDG targets

Inter Press Service examines the Stand Up Take Action campaign, which took place October 16-18 to highlight the Millennium Development Goals' [MDG] 2015 deadline.

19 Oct 2009

Failure to correct hearing loss may lead brain to forget how to hear and understand speech

Most of the 28 million Americans living with untreated hearing loss may not be aware that failure to take corrective action could result in the brain actually "forgetting" how to hear and understand speech, warns HearUSA audiologist Cindy Beyer.

19 Oct 2009

Viriom picks ChemDiv's Russian subsidiary for development of innovative HIV compounds

ChemDiv, Inc. of San Diego has proudly announced that its wholly owned subsidiary Chemical Diversity Research Institute (CDRI ) of Moscow, Russia, has been chosen by Viriom Ltd. ( Viriom) of Moscow, Russia as a service partner in developing innovative HIV compounds. The program includes pre-clinical and clinical studies, which are expected to begin in 2010.

19 Oct 2009

First Edition: October 19, 2009

Five Rivers Medical Center in Pocahontas, Ark., needs help to get a highly coveted "critical access" hospital designation - and the extra Medicare funding that comes with it. Sen. Mark Pryor, an Arkansas Democrat, intends to provide it.

19 Oct 2009

New decision-making tool offers breast reconstruction options post cancer surgery

A computer-based decision-making aid may make it possible for more women to have breast reconstruction after surgical treatment for cancer.

19 Oct 2009

IAVI and Ragon Institute sign MOU to devise new vaccine strategies for AIDS

The International AIDS Vaccine Initiative (IAVI) announced today that it has signed a memorandum of understanding with the Ragon Institute to accelerate the development of new and promising AIDS vaccine candidates for testing.

19 Oct 2009

IL-2 compound ineffective against HIV-AIDS

An international research team has demonstrated that treating HIV-AIDS with interleukin-2 (IL-2) is ineffective. As a result, the researchers recommend that clinical trials on this compound be stopped.

19 Oct 2009

TheraDoc commences beta testing of new computerized patient surveillance tool

TheraDoc®, the leading provider of clinical decision support technology in healthcare, today announced that it has started beta testing of a new computerized patient surveillance tool that will help hospitals monitor and manage screening programs for multidrug-resistant organisms (MDROs), such as methicillin-resistant Staphylococcus aureus, or MRSA, which every year kills more people in the United States than AIDS.

19 Oct 2009

More nutrition guidance needed to build good eating habits in growing children, says Nestle FITS survey

Parents and caregivers are hearing and following the feeding guidance for infants, yet continued work needs to be done to help them also build good eating habits for their growing children, suggests data from the Nestle Feeding Infants and Toddlers Study (FITS) released today at a symposium at the American Dietetic Association's Food & Nutrition Conference & Expo.

19 Oct 2009

Novel HIV drug to be studied in cell cultures and patients

A $6 million, five-year federal grant to The Children's Hospital of Philadelphia Research Institute will enable researchers to investigate a novel approach in treating HIV infection---a unique class of drugs focused on developing therapies for psychological and neurological effects in AIDS.

19 Oct 2009

AIDS News and Research

Boehringer Ingelheim continues providing non assert declarations to manufacture HIV/AIDS medicines

GlaxoSmithKline to allow Apotex continue manufacturing their drug in Rwanda

AHF reiterates its disappointment over the presentation of Thai HIV vaccine study data

Trial collaborators present results from Prime-Boost HIV Vaccine Clinical Trial

Shire Canada supports initiative for further access to antiretroviral medicine for Rwanda

Opinions: HIV vaccine; HIV resources help promote global disease control; U.S. fight against world hunger

DC 'squanders' AIDS money on questionable groups despite urgent needs

Scientists find cause for lupuslike disease in mice

Innovative financing for global health issues discussed at Nairobi meeting

Also in Global Health News: Asia-Pacific reproductive health; developing country medical waste disposal; draft bill in Uganda; diarrhea deaths in China

Campaign seeks to hold governments accountable to meeting MDG targets

Failure to correct hearing loss may lead brain to forget how to hear and understand speech

Viriom picks ChemDiv's Russian subsidiary for development of innovative HIV compounds

First Edition: October 19, 2009

New decision-making tool offers breast reconstruction options post cancer surgery

IAVI and Ragon Institute sign MOU to devise new vaccine strategies for AIDS

IL-2 compound ineffective against HIV-AIDS

TheraDoc commences beta testing of new computerized patient surveillance tool

More nutrition guidance needed to build good eating habits in growing children, says Nestle FITS survey

Novel HIV drug to be studied in cell cultures and patients

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News